Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heme polymerization is a crucial detoxification pathway in malaria parasites (Plasmodium spp.) where toxic free heme, released during hemoglobin digestion, is converted into an inert crystalline pigment called hemozoin. This process is essential for parasite survival as free heme is highly toxic. Inhibition of heme polymerization is a validated antimalarial drug target.
Inhibition of heme polymerization leading to accumulation of toxic free heme.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heme Polymerization.